Suppr超能文献

清醒自发性高血压大鼠去甲肾上腺素清除率及向血浆溢出率的测定。

The measurement of norepinephrine clearance and spillover rate into plasma in conscious spontaneously hypertensive rats.

作者信息

Keeton T K, Biediger A M

机构信息

Department of Pharmacology, University of Texas Health Science Center, San Antonio 78284.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1988 Oct;338(4):350-60. doi: 10.1007/BF00172109.

Abstract

The clearance of norepinephrine from plasma and the spillover rate of norepinephrine into plasma were determined in conscious unrestrained spontaneously hypertensive rats by measuring the concentrations of 3H-norepinephrine and norepinephrine in arterial plasma after 90 min of i.v. infusion with 3H-norepinephrine. In 50 conscious spontaneously hypertensive rats treated with saline (control animals), the following basal values were obtained: plasma norepinephrine concentration = 149 +/- 5 pg/ml; plasma epinephrine concentration = 61 +/- 4 pg/ml; norepinephrine clearance = 188 +/- 4 ml min-1 kg-1; and norepinephrine spillover rate = 27.5 +/- 0.8 ng min-1 kg-1. A significant portion of infused 3H-norepinephrine appeared to be cleared from the plasma by the uptake1 process, since desipramine decreased norepinephrine clearance by 32%. The vasodilating agents hydralazine and minoxidil produced dose-related increases in norepinephrine spillover rate and plasma norepinephrine concentration, but the percent increases in norepinephrine spillover rate exceeded the percent increases in plasma norepinephrine concentration because of concomitant increases in norepinephrine clearance, particularly after treatment with minoxidil. The increase in norepinephrine clearance caused by hydralazine and minoxidil probably resulted from the increase in cardiac output and resultant increase in hepatic and/or pulmonary blood flow. Adrenal secretion of norepinephrine did not appear to contribute to the elevation in norepinephrine spillover rate elicited by hydralazine and minoxidil. Chlorisondamine suppressed norepinephrine spillover rate by 77%, in association with a 70% decline in plasma epinephrine concentration, whereas bretylium lowered norepinephrine spillover rate by only 41%, with no change in plasma epinephrine concentration. The decrements in norepinephrine clearance caused by chlorisondamine (-23%) and bretylium (-15%) were more or less proportional to the magnitude of the vasodepression caused by these drugs. Both norepinephrine spillover rate and clearance fell in a dose-related fashion after treatment with clonidine. After treatment with the sympathoinhibitory agents chlorisondamine, bretylium and clonidine, the percent decreases in norepinephrine spillover rate always exceeded the percent decreases in plasma norepinephrine concentration. Based on these observations, we conclude that norepinephrine spillover rate provides a more accurate measurement of the activity of the peripheral sympathetic nervous system than does plasma norepinephrine concentration in conscious spontaneously hypertensive rats.

摘要

通过静脉注射3H-去甲肾上腺素90分钟后,测量清醒、不受束缚的自发性高血压大鼠动脉血浆中3H-去甲肾上腺素和去甲肾上腺素的浓度,测定血浆中去甲肾上腺素的清除率以及去甲肾上腺素向血浆中的溢出率。在50只接受生理盐水治疗的清醒自发性高血压大鼠(对照动物)中,获得了以下基础值:血浆去甲肾上腺素浓度 = 149 ± 5 pg/ml;血浆肾上腺素浓度 = 61 ± 4 pg/ml;去甲肾上腺素清除率 = 188 ± 4 ml·min-1·kg-1;去甲肾上腺素溢出率 = 27.5 ± 0.8 ng·min-1·kg-1。由于地昔帕明使去甲肾上腺素清除率降低了32%,因此注入的3H-去甲肾上腺素的很大一部分似乎是通过摄取1过程从血浆中清除的。血管扩张剂肼屈嗪和米诺地尔使去甲肾上腺素溢出率和血浆去甲肾上腺素浓度呈剂量依赖性增加,但由于去甲肾上腺素清除率同时增加,尤其是在米诺地尔治疗后,去甲肾上腺素溢出率的增加百分比超过了血浆去甲肾上腺素浓度的增加百分比。肼屈嗪和米诺地尔引起的去甲肾上腺素清除率增加可能是由于心输出量增加以及随之而来的肝和/或肺血流量增加所致。肼屈嗪和米诺地尔引起的去甲肾上腺素溢出率升高似乎并非由肾上腺分泌的去甲肾上腺素所致。氯异吲哚铵使去甲肾上腺素溢出率降低了77%,同时血浆肾上腺素浓度下降了70%,而溴苄铵仅使去甲肾上腺素溢出率降低了41%,血浆肾上腺素浓度无变化。氯异吲哚铵(-23%)和溴苄铵(-15%)引起的去甲肾上腺素清除率下降与这些药物引起的血管减压幅度大致成比例。用可乐定治疗后,去甲肾上腺素溢出率和清除率均呈剂量依赖性下降。在用交感神经抑制药氯异吲哚铵、溴苄铵和可乐定治疗后,去甲肾上腺素溢出率的下降百分比总是超过血浆去甲肾上腺素浓度的下降百分比。基于这些观察结果,我们得出结论,在清醒的自发性高血压大鼠中,与血浆去甲肾上腺素浓度相比,去甲肾上腺素溢出率能更准确地反映外周交感神经系统的活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验